Illumina, Inc. (BMV:ILMN)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,851.00
0.00 (0.00%)
At close: Jul 18, 2025, 2:00 PM CST

Illumina Company Description

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest.

It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.

The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

The company markets and distributes its products directly to customers, as well as through life-science distributors.

Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Illumina, Inc.
CountryUnited States
Founded1998
IndustryLaboratory Analytical Instruments
Employees9,030
CEOJacob Thaysen

Contact Details

Address:
5200 Illumina Way
San Diego, Delaware 92122
United States
Phone858 202 4500
Websiteillumina.com

Stock Details

Ticker SymbolILMN
ExchangeMexican Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code3826

Key Executives

NamePosition
Jacob ThaysenChief Executive Officer
Ankur DhingraChief Financial Officer
Kevin PegelsChief Operating Officer
Brian BlanchettHead of Investor Relations